NEW SculpSure from Cynosure

The world’s first hyperthermic laser treatment for non-invasive fat reduction and body contouring was launched onto the Australian market today.

Utilising patented technology, SculpSure from Cynosure is an FDA-approved, clinically proven and effective treatment designed to reduce fat by non-invasively disrupting subcutaneous fat cells.

The versatile, hands-free, non-suction device features a flexible applicator system with the option to simultaneously treat multiple areas of the body.

The device uses a 1060nm laser and can treat an anatomical area (even two areas at once) in just 25 minutes.

“This is as much time as it takes to watch an episode of Big Bang Theory, get a ferry to Manly from Circular Quay, have a pedicure or cook a Jamie Oliver 15 minute meal,” Cynosure Australia’s Andrew Nutman told guests at a lunch at Sydney’s Park Hyatt hotel to launch the device.

Moreover, atients are able to achieve desired results without downtime or surgery. Results from can be seen approximately 6-12 weeks after treatment, as the body disposes of the fatty waste detritus through normal metabolic, lymphatic and elimination processes.

SculpSure is ideal for treating stubborn fatty layers in the flanks (love handles) and stomach. These are the areas officially approved for use by the FDA but can also be used to treat areas such as upper back and inner and outer thighs. It is suitable for both men and women.

“SculpSure represents an entirely new approach to non-invasive lipolysis, one that is clinically proven and highly effective in reducing adipose tissue and does so in significantly less time than other current treatments on the market in Australia,” said Cynosure Australia CEO Dennis Cronje.

“In a clinical trial, those treated with SculpSure saw reduction in fat layer thickness of up to 24 percent, six and 12 weeks post-treatment,” said leading Sydney plastic surgeon Dr Steven Liew (a spokesperson for SclupSure) via video.

It is intended for individuals with a body mass index (BMI) of 30 or less.


Recommended Articles